In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends
- 1 December 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 496 (2) , 534-540
Abstract
No abstract availableKeywords
Funding Information
- US Army Medical Research (W81XWH0710688, W81XWH0910711)
- NIH (1R21HL09045801, R43EB011886, 9R01EB014586)
- NSF/SBIR (1046902, 1230148)
This publication has 20 references indexed in Scilit:
- Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approachInternational Journal of Pharmaceutics, 2015
- Microspheres Prepared with PLGA Blends for Delivery of Dexamethasone for Implantable Medical DevicesPharmaceutical Research, 2013
- Polymeric “smart” coatings to prevent foreign body response to implantable biosensorsJournal of Controlled Release, 2013
- Comparison of in vitro–in vivo release of Risperdal® Consta® microspheresInternational Journal of Pharmaceutics, 2012
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Technologies for Continuous Glucose Monitoring: Current Problems and Future PromisesJournal of Diabetes Science and Technology, 2010
- Controlling Acute Inflammation with Fast Releasing Dexamethasone-PLGA Microsphere/PVA Hydrogel Composites for Implantable DevicesJournal of Diabetes Science and Technology, 2007
- Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesisJournal of Controlled Release, 2007
- Dexamethasone-Loaded Poly(Lactic-Co-Glycolic) Acid Microspheres/Poly(Vinyl Alcohol) Hydrogel Composite Coatings for Inflammation ControlDiabetes Technology & Therapeutics, 2004
- Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop reportAAPS PharmSci, 2004